Elsevier

Neuroscience Letters

Volume 467, Issue 2, 25 December 2009, Pages 90-94
Neuroscience Letters

BDNF regulates neuronal sensitivity to endocannabinoids

https://doi.org/10.1016/j.neulet.2009.10.011Get rights and content

Abstract

The diacylglycerol lipases (DAGLα/β) synthesize 2-arachidonylglycerol (2-AG), the major endocannabinoid in the developing and adult brain (eCB). This lipid acts on cannabinoid receptors to regulate axonal growth and guidance, activity-dependent synaptic plasticity and adult neurogenesis, and can also protect neurons from excitotoxicity. 2-AG action is generally terminated by monoacylglycerol lipase (MAGL), however we know very little about the mechanisms that regulate neuronal sensitivity to eCBs. In the present study we show that the brain-derived neurotrophic factor (BDNF) can determine neuronal sensitivity to eCBs. In this context, in cultured cerebellar granule neurons (CGNs) BDNF increases the expression of CB1 receptor transcripts and decreases expression of MAGL transcripts. Using phosphorylation of Akt as the readout, we show that BDNF can promote a stable increase in neuronal sensitivity to eCBs. For example, concentrations of 2-AG and noladin either (NE) that normally do not lead to Akt phosphorylation in control neurons do so in neurons pre-treated with BDNF. In addition, Akt phosphorylation in response to a wide range of concentrations of NE was always greater in neurons pre-treated with BDNF. Our data suggests the existence of a positive feedback loop that might sustain neuronal survival in the normal brain.

Section snippets

Acknowledgement

This work was supported by the BBSRC.

References (34)

  • T. Sugiura et al.

    2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

    Biochem. Biophys. Res. Commun.

    (1995)
  • S. Watson et al.

    The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation

    Mol. Cell. Neurosci.

    (2008)
  • E.J. Williams et al.

    Evidence for and against a pivotal role of PI 3-kinase in a neuronal cell survival pathway [published erratum appears in Mol Cell Neurosci 2000 Mar;15(3):330]

    Mol. Cell. Neurosci.

    (1999)
  • T. Aguado et al.

    The endocannabinoid system drives neural progenitor proliferation

    FASEB J.

    (2005)
  • E. Aso et al.

    BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice

    J. Neurochem.

    (2008)
  • B.S. Basavarajappa et al.

    Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration

    Mini Rev. Med. Chem.

    (2009)
  • P. Berghuis et al.

    Hardwiring the brain: endocannabinoids shape neuronal connectivity

    Science

    (2007)
  • Cited by (57)

    • Distribution of the endocannabinoid system: Linking signaling and development

      2023, Neurobiology and Physiology of the Endocannabinoid System
    • Mechanisms of endocannabinoid control of synaptic plasticity

      2021, Neuropharmacology
      Citation Excerpt :

      In this regard, ketamine (a known modifier of synaptic plasticity; Luo et al., 2020; Maren et al., 1991; Salami et al., 2000; Stringer and Guyenet, 1983), was shown to increase 2-AG levels in the dorsal striatum by increasing the expression of PR domain protein 5 (PRDM5), which functions as a transcriptional repressor of MAGL (Xu et al., 2020). Similarly, a link between presynaptic BDNF signalling, reduced MAGL expression but increased CB1R expression in cultured cerebellar granule neurons has been reported (Maison et al., 2009). Although as previously stated, the interaction between BDNF and eCB signalling is complex, since BDNF also acts at postsynaptic sites to facilitate or inhibit eCB-plasticity (see section 4.1.1).

    • Resilience to fear: The role of individual factors in amygdala response to stressors

      2021, Molecular and Cellular Neuroscience
      Citation Excerpt :

      Interestingly, BDNF is strongly interconnected with the eCB system. Activation of the post-synaptic BDNF receptor (TrKB) leads to the release of eCBs, to an increase in transcription and translation of CB1R and higher CB1R responses to agonists (Andero and Ressler, 2012; Maison et al., 2009). In turn, activation of CB1R can modulate the expression of several downstream genes, including BDNF.

    • The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease

      2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      A recent finding demonstrated that the induction of BDNF gene expression mediated by CB1 receptors relies on the activation of the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin complex 1(mTORC1) pathway (Blazquez et al., 2015). Taken phosphorylated Akt as the indicator, BDNF was also shown to promote a stable increase in neuronal sensitivity to ECS (Maison et al., 2009). In addition, neurogenesis mediated by stimulation of CB1 receptors also can be improved through antagonizing the neurotoxicity effect of NO (Kim et al., 2006b).

    • Levetiracetam combined with ACEA, highly selective cannabinoid CB1 receptor agonist changes neurogenesis in mouse brain

      2019, Neuroscience Letters
      Citation Excerpt :

      Neurotrophic factors are highly linked to adult neurogenesis and latest sources imply a functional interplay between BDNF and CB1 receptors in the brain [68]. To back up this statement Maison et al. [69] proved that BDNF increases the expression of CB1 receptors in rat cultured cerebellar granule neurons, while BDNF promotes the production of cortical endocannabinoids [70]. Additionally, up to date evidence reveal that cannabinoids can target the actin-bundling protein fascin, which are important in the migration of neuroblasts and neural development [71].

    View all citing articles on Scopus
    View full text